Literature DB >> 18385388

Rituximab in membranous nephropathy after haematopoietic stem cell transplantation.

Michele Ferrannini, Gisella Vischini, Nicola Di Daniele.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18385388     DOI： 10.1093/ndt/gfn110

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

Review 1.  Chronic kidney disease after hematopoietic stem cell transplantation.

Authors:  Eric P Cohen; Priya Pais; John E Moulder
Journal:  Semin Nephrol       Date:  2010-11       Impact factor: 5.299

Review 2.  Rituximab therapy for membranous nephropathy: a systematic review.

Authors:  Andrew S Bomback; Vimal K Derebail; Julie G McGregor; Abhijit V Kshirsagar; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-11       Impact factor: 8.237

3.  Membranous nephropathy in autologous hematopoietic stem cell transplant: autologous graft-versus-host disease or autoimmunity induction?

Authors:  Ala Abudayyeh; Luan D Truong; Laurence H Beck; Donna M Weber; Katy Rezvani; Maen Abdelrahim
Journal:  Clin Kidney J       Date:  2015-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.